PhaseBio Pharmaceuticals, Inc. (PHAS)

Asset Growth

20.22%

Fiscal year · Period ending:

PHAS logo

PHAS Asset Growth

Latest reported20.22%
PHAS FY Asset Growth (YoY) (0.00% → 20.22%)
High-resolution chart · PNG

PHAS asset growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Asset Growth — Annual fiscal periods
Period endingAsset Growth
20.2216%
-38.9568%
30.8888%
347.0246%
242.4581%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.